Recipharm
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Sweden · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Drottninggatan 29, Stockholm, Stockholm,...Phone Number
+46 86025200Website
www.recipharm.comRevenue
$1.5 BillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
6
1
1
1
2
About Recipharm
Established in 1995 and headquartered in Stockholm, Sweden, Recipharm is a contract development and manufacturing organization. The company focuses on supporting pharmaceutical companies by helping them manage products from early development through to commercial manufacturing.Explore more
Recipharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Recipharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Recipharm has new funding data
Product Launch: Get notified when Recipharm launches new products
Earning: See what the market has to say on Recipharm recently announced quarterly report
Check out if Recipharm is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Recipharm has recently received funding, and reach out quickly before it becomes old news!
Recipharm, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Recipharm had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Recipharm
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Recipharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Recipharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Recipharm.
Recipharm financials insights
Gather financial insights about Recipharm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Share Placement
$20M
2012
Debt
$101.3M
2014
Stock Offering
$87M
Debt
$160.2M
2016
Stock Offering
$29.5M
Debt
$106.8M
2018
Stock Offering
$54.2M
2020
Stock Offering
$53.4M
Recipharm Tech Stack
A closer look at the technologies used by Recipharm
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Compliance, Logistics / Supply Chain, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Recipharm has more open roles in Operations than it has had at any time in the past 9 months. Technologies mentioned include: SAP ERP, Persona, and SAP.
Hiring Plans
Hiring Plans
Recipharm has more open roles in Finance than it has had at any time in the past 6 months.
Hiring Plans
Hiring Plans
Hiring Plans
Recipharm News & Media
NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics
LAUSANNE, Switzerland and BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation company enabling efficient, cost-effective, and scalable production of viral vectors for cell and gene therapy (C>), today announced it has granted a non-exclusive technology license to ReciBioPharm – Recipharm’s Advanced Therapies (ATMP) division and a leading Contract Development and Manufacturing Organization (CDMO) – to provide global biotech and pharma companies with access to NewBiologixHealthcare CMO Market Hits New High | Major Giants Almac Group, Lonza, Recipharm AB
HTF MI recently introduced Global Healthcare CMO Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaboratesRecipharm’s full range Oral Solid Dosage (OSD) capabilities meet growing industry demands
· Full range OSD development and manufacturing capabilities from orphan drugs to blockbusters · High potency manufacturing capabilities expansion · Introduction of ReciPredict platform to accelerate product development and de-risk tech transfer · API capabilities from route scouting to large scale synthesis Recipharm, a leading global contract development and manufacturing organisation (CDMO), has significantly enhanced its capabilities in the development and production of orally delivered drugRecipharm strengthens pharmaceutical development capabilities with strategic investments
· New investments include expanded capabilities in Oral Solid Dosage (OSD), Sterile Fill & Finish (SFF) and complement existing development capabilities. · New product development lab for sterile liquids and lyo products, as well as GMP pilot scale lines for BFS, PFS and vials. · Expanded labs and new GMP pilot scale equipment for product development. · Investment in analytical labs’ Extractables and Leachables, Nitrosamines and Elemental Impurities capabilities. · Group offering now covers all
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Recipharm
Sign Up For FreeTo access detailed company insights
Established in 1995 and headquartered in Stockholm, Sweden, Recipharm is a contract development and manufacturing organization. The company focuses on supporting pharmaceutical companies by helping them manage products from early development through to commercial manufacturing.... Read More
